Table 4.

Clinical and epidemiological data from the 10 cases of proven Candida parapsilosis (sensu stricto) fungemia at HUMAP-UFMS.

	Patient data
Isolate	Underlying conditions	Days of hospitalization before candidemia	Central venous catheter at candidemia	Previous antibiotic exposure	Previous steroid exposure	Previous fluconazol and/or echinocandin exposure	Previous Candida colonization	Antifungal treatment	30-days outcome
58 H	Elderly patient, pneumonia, renal, and hepatic failure, diabetes mellitus, septic arthritis	1	Yes	No	No	No	Yes	ANF	Dead
87 H*	SLE, peritonitis abdominal surgery	21	Yes	Yes	Yes	FLC/MIF	Yes	MIF	Dead
137 H*	Elderly patient, pneumonia, infected pressure ulcer, renal failure	106	Yes	Yes	Yes	FLC	Yes	MIF	Dead
88 H*	Pulmonary PCM, acute respiratory failure	39	Yes	Yes	Yes	FLC	Yes	ANF	Alive
542 AMO*	Elderly patient, COPD, acute myocardial infarction, heart failure, ventilation-associated pneumonia	81	Yes	Yes	Yes	FLC/MIF	Yes	MIF	Dead
29 H*	HIV-associated pneumocystosis, renal failure, inflammatory bowel disease	25	Yes	Yes	Yes	FLC/ANF	Yes	ANF	Dead
188 H	Cerebral palsy, repeated pneumonia, intestinal obstruction	92	Yes	Yes	No	ANF	Yes	ANF	Dead
199 H	Renal abscess, renal failure, sickle cell disease	23	No	Yes	No	No	No	No	Alive
559 H	Prematurity, bacterial sepsis, mechanical ventilation, parenteral nutrition	24	Yes	Yes	No	No	No	AMB	Alive
662 H-II	Acute peritonitis, pelvic abscess, gastric adenocarcinoma, arrhythmia	10	Yes	Yes	No	FLC	Yes	MIF	Dead

^*Clonal isolates.

COPD, Chronic obstructive pulmonary disease; PCM, Paracoccidioidomycosis; SLE, Systemic lupus erythematosus; FLC, Fluconazole; MIF, Micafungin; ANF, Anidulafungin; AMB, Amphotericin B.